6:36 PM
 | 
Feb 28, 2008
 |  BC Extra  |  Company News

FDA approves Luvox CR

FDA approved an NDA for Luvox CR from Solvay (Euronext:SOLB) to treat obsessive compulsive disorder (OCD)...

Read the full 67 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >